人类细胞中的合成细胞间通信
1Bioengineering Department, The University of Texas at Dallas, Richardson, TX, USA; Center for Systems Biology, The University of Texas at Dallas, Richardson, TX, USA.
Cell
|August 18, 2023
概括
研究人员开发了细胞RNA输出器 (COURIER) 来包装,分泌和保护RNA分子. 这一突破使得复杂的细胞间RNA通信成为可能,
科学领域:
- 分子生物学
- 细胞生物学
- 生物化学
背景情况:
- 人类细胞内RNA的选择性包装,输出和回收是一个重大挑战.
- 了解RNA流通对于细胞功能和细胞间通信至关重要.
研究的目的:
- 开发用于RNA运输的新型分子快递器.
- 设计控制RNA输出和回收的系统.
- 建立复杂的细胞间RNA通信的基础.
主要方法:
- 开发工程细胞RNA输出器 (COURIER).
- 包装RNA货物的快递员的能力.
- 对CURIER的分泌和保护机制的评估.
- 对促进细胞间RNA通信的快递器的研究.
主要成果:
- 成功开发能够包装RNA的快递器.
- 证明快递器分泌和保护RNA货物的能力.
- 建立作为细胞间RNA转移的可行系统的快递器.
结论:
- 快递器代表了针对性RNA传递和细胞间通信的新工具.
- 这项工作为RNA疗法和合成生物学中的先进应用奠定了基础.
- 设计的CURIER系统为研究和操纵RNA生物学提供了新的可能性.
相关概念视频
Cell-surface Signaling
51.9K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.9K
What is Cell Signaling?
119.3K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
119.3K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K


